Lesch-Nyhan syndrome and its pathogenesis: purine concentrations in plasma and urine with metabolite profiles in CSF

• Published in: Journal of inherited metabolic disease Vol. 11; no. 3; p. 239
• Main Authors: Harkness, R A, McCreanor, G M, Watts, R W
• Format: Journal Article
• Language: English
• Published: United States 01.09.1988
• Subjects: Allopurinol - therapeutic use; Child; Child, Preschool; Creatinine - urine; Female; Heterozygote; Humans; Hypoxanthine Phosphoribosyltransferase - metabolism; Hypoxanthines - urine; Infant; Infant, Newborn; Lesch-Nyhan Syndrome - drug therapy; Lesch-Nyhan Syndrome - genetics; Lesch-Nyhan Syndrome - metabolism; Male; Purines - metabolism; Uridine - blood; Uridine - cerebrospinal fluid; Xanthines - urine
• ISSN: 0141-8955; 1573-2665
• DOI: 10.1007/BF01800365

Purine metabolism in the Lesch-Nyhan syndrome has been re-examined in 10 patients. Hypoxanthine and xanthine concentrations in plasma and CSF and urinary excretion have been studied, on and off allopurinol treatment, using high performance liquid chromatographic methods. Accumulation of the substrate, hypoxanthine, of the missing hypoxanthine guanine phosphoribosyltransferase (HPRT) enzyme, is more marked in urine and in CSF than in plasma. The greater increase in CSF is consistent with the most metabolically active tissue, brain, showing the most marked functional changes. The function of HPRT seems to be the recycling of hypoxanthine which is released from tissues in increasing quantities as energy use, ATP 'turnover', in the tissue increases. The existing screening method for HPRT deficiency, the ratio of the urinary concentration of urate to that of creatinine, shows overlap between the values in severe HPRT deficiency and in controls; this overlap is not found with a urinary hypoxanthine/creatinine molar concentration ratio.